Track CaliPharms's accounts payable ($1.8M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
CaliPharms (KGET) currently reports a accounts payable of $1.8M as of September 2014. In the prior-year period, the figure was $0. Use the charts on this page to explore CaliPharms's accounts payable history and peer comparisons.
CaliPharms's accounts payable changed from $0 to $1.8M (period ending September 2014). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
CaliPharms reported $1.8M in accounts payable as of September 2014. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current accounts payable of $1.8M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for CaliPharms, and consider following KGET for alerts when major investors trade the stock.
CaliPharms is classified in the Industrials sector. On accounts payable, it currently shows $1.8M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Industrials are usually more informative than comparing KGET with unrelated industries.